Key facts
| Price (PPV) | 134.90 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | celecoxib |
| Class | Antiinflammatory and antirheumatic products |
| ATC code | M01AH01 |
| Manufacturer | NOVOPHARMA |
| Presentation | Boite de 20 |
| Hospital price | 84.30 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement symptomatique des inflammations et des douleurs provoquées par l'ostéoarthrose, la polyarthrite chronique (arthrite rhumatoïde) et par la spondylarthrite ankylosante (maladie de Bechterew). Traitement symptomatique de l'arthrite juvénile idiopathique chez l'enfant et l'adolescent d'un poids corporel supérieur à 25 kg. La décision de prescrire un inhibiteur sélectif de la COX-2 doit tenir compte de l'ensemble des facteurs de risque d'un patient (voir sous «Contre-indications» et «Mises en garde et précautions»).
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
In Morocco, 7 other products contain the same active substance as Voxcib 200 mg (Celecoxib), at the same strength and in the same dosage form. For the same pack size (Boite de 20), the cheapest is Celephi 200 mg (PHI) at 130.80 MAD, i.e. 3 % less than Voxcib 200 mg (134.90 MAD). The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Celephi 200 mg | PHI | Boite de 20 | 130.80 MAD | 6.54 / unit | −3 % |
| Isox 200 mg | PROMOPHARM (HIKMA) | Boite de 20 | 134.90 MAD | 6.75 / unit | — |
| Celebrex 200 mg | VIATRIS PHARMACEUTICALS | Boîte de 20 | 150 MAD | 7.50 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Celephi 200 mg | PHI | Boite de 10 | 70.10 MAD | 7.01 / unit |
| Isox 200 mg | PROMOPHARM (HIKMA) | Boite de 10 | 76.60 MAD | 7.66 / unit |
| Voxcib 200 mg | NOVOPHARMA | Boîte de 10 | 76.60 MAD | 7.66 / unit |
| Celebrex 200 mg | VIATRIS PHARMACEUTICALS | Boîte de 10 | 83.20 MAD | 8.32 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Voxcib 200 mg
Voxcib 200 mg belongs to the antiinflammatory and antirheumatic products therapeutic class. In Morocco, this drug is marketed by NOVOPHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Voxcib 200 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Voxcib 200 mg
Answers to common questions from Moroccan patients about this drug.